Thursday, 21 October 2021 08:10 GMT

Shining the Spotlight on Binge-Eating Disorder


(MENAFN- Investor Brand Network) Research shows that binge-eating disorder, which is more common than other eating disorders such as bulimia and anorexia, affects more women than men. Experts say that despite popular opinion that binge eating is a mood or phase, it is a serious issue that needs to be addressed. Regence BlueCross BlueShield 's executive medical director Dr. Amy Khan states that eating disorders often represent serious mental health conditions.

Khan explains that eating disorders are serious ailments that can impact an individual's social, emotional and physical functioning. This is in addition to affecting their cardiovascular…

Read More >>

NOTE TO INVESTORS: The latest news and updates relating to Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) available in the company's newsroom at 

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime . As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text“STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit 

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: 

BioMedWire (BMW)
San Francisco, California

415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork .

MENAFN14102021000224011066ID1102972732


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.